Jan W. Drijfhout

27.0k total citations · 4 hit papers
319 papers, 21.2k citations indexed

About

Jan W. Drijfhout is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jan W. Drijfhout has authored 319 papers receiving a total of 21.2k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Immunology, 118 papers in Molecular Biology and 70 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jan W. Drijfhout's work include Immunotherapy and Immune Responses (105 papers), T-cell and B-cell Immunology (69 papers) and Monoclonal and Polyclonal Antibodies Research (68 papers). Jan W. Drijfhout is often cited by papers focused on Immunotherapy and Immune Responses (105 papers), T-cell and B-cell Immunology (69 papers) and Monoclonal and Polyclonal Antibodies Research (68 papers). Jan W. Drijfhout collaborates with scholars based in Netherlands, United States and United Kingdom. Jan W. Drijfhout's co-authors include Cornelis J.M. Melief, Peter A. van Veelen, Sjoerd H. van der Burg, Frits Koning, Rienk Offringa, W. Martin Kast, Gemma G. Kenter, Willemien E. Benckhuijsen, Kees L. M. C. Franken and Gert Jan Fleuren and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jan W. Drijfhout

318 papers receiving 20.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

2009 803 citations Gemma G. Kenter, Marij J.P. Welters et al. profile →
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

1993 709 citations Jan W. Drijfhout, Cornelis J.M. Melief et al. profile →
Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

1998 594 citations Jan W. Drijfhout et al. The Journal of Experimental Medicine profile →
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms

2018 426 citations Anna de Breij, Martijn Riool et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan W. Drijfhout Netherlands	77	11.4k	6.8k	4.2k	3.7k	2.6k	319	21.2k
James McCluskey Australia	80	16.7k 1.5×	4.6k 0.7×	3.5k 0.8×	2.9k 0.8×	1.3k 0.5×	347	23.0k
Lennart Hammarström Sweden	71	12.2k 1.1×	4.4k 0.7×	2.3k 0.5×	1.2k 0.3×	4.4k 1.7×	509	20.1k
Hans‐Georg Rammensee Germany	81	19.6k 1.7×	11.3k 1.7×	3.7k 0.9×	6.0k 1.6×	1.9k 0.7×	361	28.0k
Mitchell Kronenberg United States	103	30.7k 2.7×	5.2k 0.8×	3.5k 0.8×	6.1k 1.6×	2.5k 1.0×	344	37.0k
Dennis A. Carson United States	88	11.1k 1.0×	11.4k 1.7×	3.0k 0.7×	5.7k 1.5×	1.8k 0.7×	467	29.3k
Bernard Malissen France	95	27.2k 2.4×	7.6k 1.1×	2.2k 0.5×	4.9k 1.3×	2.2k 0.8×	399	35.4k
Raif S. Geha United States	99	19.4k 1.7×	5.3k 0.8×	2.4k 0.6×	2.7k 0.7×	3.2k 1.3×	501	31.8k
Tsuneyasu Kaisho Japan	73	30.2k 2.6×	9.6k 1.4×	6.1k 1.4×	5.0k 1.4×	1.8k 0.7×	165	40.3k
John W. Kappler United States	108	32.5k 2.8×	8.3k 1.2×	2.9k 0.7×	5.5k 1.5×	4.1k 1.6×	372	42.3k
P Vassalli Switzerland	76	10.2k 0.9×	6.1k 0.9×	2.5k 0.6×	2.1k 0.6×	1.7k 0.6×	209	22.4k

Countries citing papers authored by Jan W. Drijfhout

Since Specialization

Citations

This map shows the geographic impact of Jan W. Drijfhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan W. Drijfhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan W. Drijfhout more than expected).

Fields of papers citing papers by Jan W. Drijfhout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan W. Drijfhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan W. Drijfhout. The network helps show where Jan W. Drijfhout may publish in the future.

Co-authorship network of co-authors of Jan W. Drijfhout

This figure shows the co-authorship network connecting the top 25 collaborators of Jan W. Drijfhout. A scholar is included among the top collaborators of Jan W. Drijfhout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan W. Drijfhout. Jan W. Drijfhout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dirven, Richard, Ruben Bierings, Caterina Casari, et al.. (2025). Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs. Blood Advances. 9(2). 310–320. 6 indexed citations

Bos, Erik, et al.. (2023). Physical and Functional Characterization of PLGA Nanoparticles Containing the Antimicrobial Peptide SAAP-148. International Journal of Molecular Sciences. 24(3). 2867–2867. 15 indexed citations

Bovenkamp, Fleur S. van de, Jos Pool, Cynthia S. M. Kramer, et al.. (2023). Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation. Proceedings of the National Academy of Sciences. 120(50). e2310666120–e2310666120. 9 indexed citations

Riool, Martijn, Leonie de Boer, Robert A. Cordfunke, et al.. (2023). CalcAMP: A New Machine Learning Model for the Accurate Prediction of Antimicrobial Activity of Peptides. Antibiotics. 12(4). 725–725. 19 indexed citations

Dijksteel, Gabrielle S., Magda M. W. Ulrich, Peter H. Nibbering, et al.. (2020). The functional stability, bioactivity and safety profile of synthetic antimicrobial peptide SAAP-148. 12(2). 70–80. 5 indexed citations

Boer, Leonie de, et al.. (2018). Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus aureus. International Journal of Antimicrobial Agents. 53(2). 143–151. 46 indexed citations

Breij, Anna de, Martijn Riool, Robert A. Cordfunke, et al.. (2018). The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Science Translational Medicine. 10(423). 426 indexed citations breakdown →

Cools, Tanne L., Kim Vriens, Sara Verbandt, et al.. (2017). The Antifungal Plant Defensin HsAFP1 Is a Phosphatidic Acid-Interacting Peptide Inducing Membrane Permeabilization. Frontiers in Microbiology. 8. 36 indexed citations

Veelen, Peter A. van, Michael Mähler, George M. C. Janssen, et al.. (2013). Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmunity Reviews. 13(3). 225–230. 95 indexed citations

10.

Stuart, A. A. Verrijn, et al.. (2012). CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clinical & Experimental Immunology. 170(1). 57–65. 37 indexed citations

11.

Tjin, Esther P.M., Debby Konijnenberg, Henk Mallo, et al.. (2011). T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy. Clinical Cancer Research. 17(17). 5736–5747. 32 indexed citations

12.

Velthuis, J., Wendy W. J. Unger, Joana R. F. Abreu, et al.. (2010). Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers. Diabetes. 59(7). 1721–1730. 159 indexed citations

13.

Oliveira, Cláudia C., Peter A. van Veelen, Bianca Querido, et al.. (2009). The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. The Journal of Experimental Medicine. 207(1). 207–221. 78 indexed citations

14.

Melief, Cornelis J.M., Marij J.P. Welters, Margriet J. Löwik, et al.. (2008). Robust T-cell responses and clinical responses following long peptide vaccination against high risk HPV-16. 8. 2. 1 indexed citations

15.

Herberts, Carla, Joost Neijssen, Lennert Janssen, et al.. (2006). Cutting Edge: HLA-B27 Acquires Many N-Terminal Dibasic Peptides: Coupling Cytosolic Peptide Stability to Antigen Presentation. The Journal of Immunology. 176(5). 2697–2701. 33 indexed citations

16.

Welters, Marij J.P., Dmitri V. Filippov, Susan J. F. van den Eeden, et al.. (2004). Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model. Vaccine. 23(3). 305–311. 15 indexed citations

17.

Tjabringa, G. Sandra, Jamil Aarbiou, Dennis K. Ninaber, et al.. (2003). The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor. The Journal of Immunology. 171(12). 6690–6696. 325 indexed citations

18.

Roos, Anja, Alma J. Nauta, Maria C. Faber‐Krol, et al.. (2001). Specific Inhibition of the Classical Complement Pathway by C1q-Binding Peptides. The Journal of Immunology. 167(12). 7052–7059. 80 indexed citations

19.

Geluk, Annemieke, Krista E. van Meijgaarden, Kees L. M. C. Franken, et al.. (2000). Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A*0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans. The Journal of Immunology. 165(11). 6463–6471. 129 indexed citations

20.

Hart, Bert A. ‘t, Diënne G. Elferink, Jan W. Drijfhout, et al.. (1997). Liposome‐mediated peptide loading of MHC‐DR molecules in vivo. FEBS Letters. 409(1). 91–95. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact